PRESS RELEASES
EDAP Announces Exclusive Worldwide Distribution Rights to Exact Imaging’s Micro-Ultrasound Technologies
  • Exact Imaging is a leading developer of ultra-high-resolution micro-ultrasound diagnostic technologies
  • Micro-ultrasound ExactVu™ is the only ultrasound-based imaging tool with published data demonstrating prostate cancer diagnostic capabilities similar to MRI
  • Combination of Exact Imaging’s micro-ultrasound and EDAP’s Focal One® represents the most complete offering for the focal management of prostate cancer
  • Represents a potentially meaningful new growth driver for EDAP

LYON, France, May 12, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, announced today that the company has signed an exclusive worldwide distribution agreement with Exact Imaging, a developer of high resolution micro-ultrasound imaging technologies. Under the terms of the agreement, EDAP will market Exact Imaging’s micro-ultrasound diagnostic devices alongside its Focal One high intensity focused ultrasound (HIFU) treatment solution. The combination of these technologies represents the most complete end-to-end solution, from diagnosis through treatment, available to urologists today.



2020

2019

2018

2017

2016

2015



© 2020 Exact imaging
ExactVu™, Exact Imaging™, PRI-MUS™, FusionVu™, Cognitive Assist™ and ExactVu Micro Doppler™ are trademarks of Exact Imaging.
ExactVu™ micro-ultrasound system is available for sale in the European Union (CE Mark), the United States (FDA 510(k) clearance), and in Canada (Health Canada license).